drugset / Trial / NCT07405177
A Study of MK-7240 in Healthy Participants (MK-7240-009)
RandomizedParallel-groupOpen-labelBasic science
Summary
The goal of this study is to learn what happens to MK-7240 in a healthy person's body over time (pharmacokinetic or PK study). Researchers also want to learn about the safety of MK-7240 and if people tolerate it.
Timeline
- Start
- 2026-03-05
- Primary completion
- 2026-09-03
- Completion
- 2026-09-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tulisokibart | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.